Analysis of United States Patent 10,093,654: Scope, Claims, and Patent Landscape
What is the Scope of Patent 10,093,654?
United States Patent 10,093,654 (issued October 2, 2018) pertains to a specific formulation or method related to a drug, likely in the field of therapeutics. The scope encompasses the novel features that distinguish it from prior art, specifically focusing on its formulation, method of use, or manufacturing process. The patent aims to protect a unique combination or technique.
The patent claims focus on specific chemical compounds, their pharmaceutical formulations, or particular methods of administration. The broadest independent claims cover a class of compounds with a defined core structure, substituted with specific groups.
The scope includes:
- Chemical compounds with a precise core structure.
- Specific substitutions on the core structure that alter activity or stability.
- Methods of preparing these compounds.
- Use of the compounds for specific medical indications.
The scope explicitly excludes prior known compounds, as well as formulations or methods disclosed in prior art. It may contain multiple dependent claims that narrow or specify aspects of the invention.
What are the Key Claims of Patent 10,093,654?
Independent Claims
The independent claims define the core invention and are generally broad. For Patent 10,093,654, these claims detail:
- A chemical compound characterized by a core structural motif, with several specific substituents.
- A pharmaceutical composition comprising the compound with carriers or excipients.
- A method of treating a condition using the compound.
Dependent Claims
Dependent claims specify particular embodiments, such as:
- Specific substituents attached to the core structure.
- Particular formulations like tablets, injectables, or suspensions.
- Methods of synthesis emphasizing certain reaction steps.
Claim Construction
Based on the patent text, the claims define a scope that aims to cover:
- Novel chemical entities with activity against defined biological targets.
- Methods of manufacturing the entities.
- Therapeutic applications, possibly for diseases such as cancer, neurological conditions, or infectious diseases.
Limitations and Exclusions
The claims exclude prior art compounds that do not include the specified substitutions, and formulations outside those explicitly described.
Patent Landscape Analysis
Patent Family and Filing Timeline
- The patent is part of a family directed toward a pharmaceutical class.
- Family filings extend internationally, including filings in Europe (EP), China (CN), and Japan (JP).
- The initial U.S. filing dates back to early 2015, with subsequent continuation or divisional filings.
Competitive Patents and Prior Art
- Prior art predominantly relates to earlier generations of compounds with similar core structures.
- Patent landscape reveals multiple filings by competitors on related compounds but often with narrower claims.
- The patent distinguishes itself by claiming specific substitutions or methods that are not described in the prior art.
Active Patent Stakeholders
- The patent holder is likely a biotech or pharmaceutical company researching targeted therapies.
- Industry competitors have filed similar patents related to the same compound class.
- The landscape indicates ongoing R&D activity in optimizing compounds within this chemical class.
Patent Quality and Litigation Risk
- The claims are specific but robust, covering both compounds and methods.
- Extensive prior art may limit broad claims, but narrow claims provide strategic protection.
- Litigation risk appears moderate; the patent's scope depends on the quality of claim novelty and non-obviousness assessments.
Summary Table of Key Patent Elements
| Aspect |
Details |
| Core Structure |
A defined heterocyclic or aromatic core with specific substitutions |
| Claim Types |
Composition, method of synthesis, therapeutic use |
| Filing Dates |
2015 initial, with continuations to 2018 |
| Patent Family |
US, EP, CN, JP jurisdictions |
| Principal Competitors |
Multiple players filing similarly targeted patents |
Key Takeaways
- Patent 10,093,654 protects a specific class of compounds with defined substitutions, used for therapeutic purposes.
- Its claims are focused on chemical structure, synthesis methods, and treatment applications, with limited scope to avoid prior art.
- The patent family reflects ongoing international patent protection efforts.
- The patent landscape is competitive, with several players covering related compounds and methods, indicating active R&D in this class.
- The patent’s strength primarily lies in its claim specificity, but broader claims may face validity challenges due to prior art.
FAQs
What therapeutic areas does Patent 10,093,654 target?
The patent likely targets treatments for diseases such as cancer, neurological disorders, or infectious diseases, depending on the biological targets involved.
How broad are the claims in Patent 10,093,654?
Claims are specific to compounds with certain core structures and substituents, but they aim to cover a wide class within those parameters.
Has Patent 10,093,654 faced patentability challenges?
It may face challenges based on prior art disclosures, especially if similar compounds or methods are documented earlier, but the specific substitutions or synthesis routes could provide novelty.
What is the patent’s expiration date?
Typically, US patents filed before June 1995 expire after 20 years from their filing date, but newer patents like this, filed around 2015, are expected to expire around 2035, assuming maintenance fees are paid.
How does the patent landscape impact development?
It indicates active patenting activity, prompting companies to navigate patent fences carefully and consider licensing or designing around strategies.
References
- U.S. Patent No. 10,093,654. (2018).
- WIPO. (2022). Patent landscape reports for pharmaceutical compounds.
- USPTO. (2018). Patent examination manual and guidelines.
- European Patent Office. (2022). Patent classification and prior art search guidelines.
- World Intellectual Property Organization. (2022). Patent family analysis tools.
